COMBINATIONS OF PROGESTINES OF ENDOMETRICAL GROWTH AND PROGESTINES OF ATROPIA OF ENDOMETRIAL WITH ESTROGENES IN ORAL CONTRACEPTION

• 1. 谷氨酰胺酶抑制剂CB-839在制备治疗雌激素敏感型子宫内膜癌的药物中的应用 [P] . 中国专利： CN106860460B . 2019.04.23
• 2. 谷氨酰胺酶抑制剂CB‑839在制备治疗雌激素敏感型子宫内膜癌的药物中的应用 [P] . 中国专利： CN106860460A . 2017-06-20
• 3. COMBINATIONS OF ENDOMETRIAL CONSERVATION PROGESTINES AND ENDOMETRIAL ATROPHY PROGESTINES WITH STROGENS, IN ORAL ANTI-CONCEPTION. [P] . ES2230711T3 . 2005-05-01

  机译： 子宫内膜保守性孕激素和子宫内膜萎缩性前列腺素与雌激素的结合。

• 4. Combinations of endometrically sparing progesterones and endometrial atrophizing progesterones with estrogens in oral contraception [P] . DK1007052T3 . 2005-01-31

  机译： 口服避孕药中子宫内膜稀有孕酮和子宫内膜萎缩性孕酮与雌激素的组合

• 5. MONOFASTIC ORAL ANTICONCEPTIVE METHOD AND KIT THAT INCLUDES A COMBINATION OF PROGESTINE AND STROGEN. [P] . ES2223081T3 . 2005-02-16

  机译： 单食口服避孕药方法和试剂盒，包括前列腺素和雌激素的组合。

• 1. The efficacy of an oral probiotic combination on late onset infections, bacterial sepsis and growth of very low birth weight preterm infants (less than 1500 g). [D] . Kanic, Zlatka. 2016
• 2. No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination [O] . Doris Heger-Mahn, Günther Pabst, Angelika Dienel, 2014
• 3. Oral contraception and risk of endometrial cancer [O] . Alfred Mueck 2011

• 1. 凋膜止崩液宫腔局部应用对雌激素负荷去势大鼠子宫内膜HIF-1α和VEGF表达的影响 [C] . 王海静 ,李楠 ,白俊 . 第十七次全国中医妇科学术年会 . 2017
• 2. 雌激素依赖性子宫内膜癌组织辣椒素受体与雌激素受体亚型表达相关性研究 [A] . 张雅莉 . 2017